ALFASURE DIN 02387689
Health Canada record
| Active ingredient(s) | POLOXALENE 95 % |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 07-Jul-2012 |
| Current status date | 29-Jul-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Rafter 8 Products Inc. — licence 101045, currently licensed, last inspection rating C (2023-04-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing POLOXALENE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01911643 | BLOAT GUARD | PHIBRO ANIMAL HEALTH CORPORATION | Drug Premix | POLOXALENE 530 G | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 13381 | 2012-06-12 | New Drug Submission (NDS) |
International API supply for POLOXALENE
1 active FDA Drug Master Files.
Request a quote for ALFASURE